Annual Consultation between the GPEI and polio vaccine manufacturers, National Authorities for Containment and National Regulatory Authorities
23/09/2024
nOPV2 Safety Monitoring Guidance Manual
11/09/2024
21st Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities, 11 October 2022, Geneva, Switzerland
11/09/2024
20th Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities, 12–13 October 2021, virtual
11/09/2024
19th Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities, 12–13 October 2020, virtual
11/09/2024
18th Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities, 15 October 2019, Geneva, Switzerland
11/09/2024
17th Consultation with OPV/IPV Manufacturers and National Authorities for Containment, 9 October 2018, Geneva, Switzerland
17/05/2024
IPV request form – Dec 2016
17/05/2024
Cold chain logistics and vaccine management during SIA – May 2017
17/05/2024
mOPV2 vaccine request form – January 2021
17/05/2024
tOPV request form (for tOPV with a VVM on the label)
17/05/2024
nOPV2 Vaccine Handling
17/05/2024
nOPV2 Vaccine Management Guidance
17/05/2024
nOPV2 vaccine request form – January 2024
17/05/2024
Technical guidance mOPV2 vaccine management, monitoring, removal and disposal – May 2021